PERSUASION OR INFORMATION - PROMOTION AND THE SHARES OF BRAND NAME AND GENERIC PHARMACEUTICALS

被引：121
|
作者：
HURWITZ, MA [1 ]
CAVES, RE [1 ]
机构：
[1] HARVARD UNIV,CAMBRIDGE,MA 02138
来源：
JOURNAL OF LAW & ECONOMICS | 1988年 / 31卷 / 02期
关键词：
D O I：
10.1086/467158
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：299 / 320
页数：22
相关论文
共 50 条
  • [41] Medicines Information and the Regulation of the Promotion of Pharmaceuticals
    Alves, Teresa Leonardo
    Lexchin, Joel
    Mintzes, Barbara
    [J]. SCIENCE AND ENGINEERING ETHICS, 2019, 25 (04) : 1167 - 1192
  • [42] THE IMPACT OF GENERIC DRUG ENTRY ON MARKET SHARES AND PRICES OF BRAND-NAME DRUGS-EVIDENCE FROM CHINESE PHARMACEUTICAL MARKET
    Chen, J.
    Tian, Y.
    Shi, L. W.
    [J]. VALUE IN HEALTH, 2018, 21 : S9 - S9
  • [43] NOCEBO RESPONDING FOLLOWING TREATMENT WITH BRAND NAME OR GENERIC TABLETS
    Faasse, K.
    Petrie, K. J.
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2014, 21 : S134 - S134
  • [44] GENERIC VS BRAND-NAME DRUGS FOR THE TREATMENT OF HYPERTENSION
    Dinic, M.
    Maillard, N.
    Bouiller, M.
    Alamartine, E.
    Mariat, C.
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 : E123 - E123
  • [45] THERAPEUTIC BIOEQUIVALENCY STUDY OF BRAND NAME VERSUS GENERIC CARBAMAZEPINE
    OLES, KS
    PENRY, JK
    SMITH, LD
    ANDERSON, RL
    DEAN, JC
    RIELA, AR
    [J]. NEUROLOGY, 1992, 42 (06) : 1147 - 1153
  • [46] Assessment of Purity Parameters of Generic and Brand Name Losartan Potassium
    Mattiazzi, Patricia
    Bohrer, Denise
    Viana, Carine
    Becker, Ernilene
    [J]. CURRENT PHARMACEUTICAL ANALYSIS, 2021, 17 (01) : 129 - 139
  • [47] Brand-Name and Generic Drugs Not Equivalent in Malpractice Claims
    Vivian, Jesse C.
    [J]. US PHARMACIST, 2011, 36 (09) : 49 - 51
  • [48] BRAND VS GENERIC DRUGS - ITS ONLY A MATTER OF NAME
    SIMMONS, HE
    [J]. FDA CONSUMER, 1973, 7 (02) : 4 - 6
  • [49] Dispensing pattern of generic and brand-name drugs in children
    Chen, Alex Y.
    Wu, Susan
    [J]. AMBULATORY PEDIATRICS, 2008, 8 (03) : 189 - 194
  • [50] The effect of generic competition on the price of brand-name drugs
    Lexchin, J
    [J]. HEALTH POLICY, 2004, 68 (01) : 47 - 54
12345